Sign up to receive email updates!
- Strand Genomics Announces Availability Of Technology Solutions To Power Expansion Of Personalized Medicine Centers In U.S.
- Updated CME Program Is Designed To Help Clinicians Reduce Heart Failure Patient Hospital Readmissions
- New Global Initiative Aims to Improve Patient Outcomes in Metastatic Colorectal Cancer
- SysQuant – Pancreatic Cancer Study in PLOS ONE
- Industry-Academic Collaboration Targets Major Proteomics Quantitation Advances using Proteome Sciences’ proprietary TMT Technology
assay biomarker discovery biomarker news blood brain breast cancer cancer cells clinical trials collaboration complex detection development diagnosis diagnostic diagnostics discovery DNA drug development drugs genomics health healthcare heart imaging management medicine oncology partnership personalized medicine PR predict predictive progression response risk screening sensitivity targets therapy tissue treatment tumor tumors validation